The pyrimidine-3 mutants of Neurospora crassa have received considerable attention in the past. Mitchell and Mitchell' described experiments, using pyr-3a (37301), 3b (37815; temperature sensitive), and 3d (45502), which indicated that the pyr-3a and 3b mutations represent a genetic unit distinct from 3d. The evidence for this view was that pyrimidine-independent heterocaryons could be formed by the combination of pyr-3a or 3b with 3d; that 3d, unlike 3a or 3b, was unaffected by a suppressor, s; and that crosses between 3a or 3b and 3d gave rise to a few (less than 0.01 per cent) wild type progeny. The segregation of a closely linked colonial marker (co), however, suggested that the wild type progeny arose through a mechanism different from simple reciprocal chromosome exchange during meiosis.
The pyrimidine-3 mutants of Neurospora crassa have received considerable attention in the past. Mitchell and Mitchell' described experiments, using pyr-3a (37301), 3b (37815; temperature sensitive), and 3d (45502), which indicated that the pyr-3a and 3b mutations represent a genetic unit distinct from 3d. The evidence for this view was that pyrimidine-independent heterocaryons could be formed by the combination of pyr-3a or 3b with 3d; that 3d, unlike 3a or 3b, was unaffected by a suppressor, s; and that crosses between 3a or 3b and 3d gave rise to a few (less than 0.01 per cent) wild type progeny. The segregation of a closely linked colonial marker (co), however, suggested that the wild type progeny arose through a mechanism different from simple reciprocal chromosome exchange during meiosis.
Suyama et al. 2 have confirmed and extended these data with a large series of independently isolated pyr-3 mutants. Their work indicates that the pyr-3 locus consists, on the basis of heterocaryon complementation, of two functional units, and that a large portion of the wild type progeny arising from intercrosses of mutants can be ascribed to a mechanism ("gene conversion") which does not involve the recombination of closely linked genetic markers. All of the pyr-3 mutants, including both functional units revealed by heterocaryon complementation, appear to be arranged in a continuous, linear order, and reasonable additivity of distances prevails in the genetic map. The maximum percentage of prototrophs from crosses of mutants was approximately 0.02 per cent, which indicated a very short length of the pyr-3 complex. (The pyr-3d mutant is reported to be identical with a mutant, KS36, in one of the functional units described by Suyama et al.;2 pyr-3a and 3b presumably represent the other unit.)
Because the patterns of heterocaryon complementation or suppressor relationship observed among pyr-3 mutants has been observed in other mutant series concerned with one36 or with more than one enzyme, it cannot be decided with the evidence available whether or not all pyr-3 mutations affect a single metabolic function.
This investigation was designed to relate enzymatic features of the pyr-3 mutants to the implied physiological differences between them and to the genetic structure of the pyr-3 locus. Preliminary data have indicated that pyr-3a, 3b, and 3d, like the wild type strain, all contain the series of enzymes required for the transformation of ureido-succinic acid (US; = carbamyl aspartic acid) to uridylic acid via the orotic acid pathway, and that deficiencies in the activity of certain of these enzymes are responsible for the pyrimidine requirement of other pyr mutants.7 US does not satisfy the nutritional requirement of any of the pyr-3 mutants. The preliminary enzymatic studies, however, were considered compelling evidence that the metabolic block in pyr-3 mutants concerned the synthesis of US or earlier steps of pyrimidine metabolism.8 Attention was therefore directed to the synthesis of 677 US in pyr-3 mutants; this study deals with the enzyme, aspartic carbamyl transferase, which catalyzes the following reaction:
This enzyme has previously been demonstrated in E. coli9' 10 and higher organisms.1
The data presented here indicate a fundamental difference between pyr-3d on the one hand, and pyr-3a, 3b, and wild type on the other.
Materials and Methods.-Cultures of pyr-3a, 3b, 3d, and of wild type 5297 were obtained from the culture collection of the California Institute of Technology. Pyr-3b requires a pyrimidine as a nutritional supplement only at temperatures higher than 320C.'
Mycelia were grown for 18 to 24 hr, with shaking, in 2,500 ml culture flasks containing 700 ml minimal medium. Uridine (50 ,ug/ml) was used as a nutritional supplement for the pyrimidine mutants. The mycelia were harvested, washed, dried in a Buchner funnel, and dry powders were prepared after the pads were ground in cold acetone.
The extracts for enzyme work were prepared by extracting three grams of the powder twice with 20 ml 0. Aspartic carbamyl transferase activity was measured at 25°or 350 by the appearance of US after 15 min in the following reaction mixture: 10 ,umoles CAP, 40 ,umoles K+ I-aspartate, 250 ,umoles glycine-NaOH buffer, pH 9.1, and 0.2 to 0.4 ml of the dialyzed acetone fraction; final volume = 3.25 ml. The reaction was stopped by the addition of 0.5 ml of 2 M perchloric acid. After centrifuging the mixtures, 3 ml were passed quickly through a Dowex-50W column ( Similar extracts of pyr-3b, grown either at 250C or at 350C, were active when the reaction was carried out at 250C or at 350C, and the relationship of the activities at the two reaction temperatures was much the same as that observed in wild type extracts (Table 1) .
A further comparison of wild type and mutants was made in regard to the effects of changes in substrate concentration and the pH of the reaction mixture. By means of a Lineweaver-Burk analysis16 (Fig. 1) , the derived Km values for aspartate for the enzymes of wild type, pyr-3a, and pyr-8b (the reaction was carried out at 350C in the case of pyr-3b) were 5.0, 5.75, and 4.9 X 10-3 M, respectively. Moreover, no great differences in the dependence of the reaction on CAP concentration or pH could be observed in extracts of wild type and pyr-3a (Fig. 2) .
In contrast to extracts of pyr-3a and 3b, those of the mutant pyr-3d were consistently inactive (Table 1) ; an activity of one per cent of the wild type extracts would have been detected. When an extract of pyr-3d was added to wild type or pyr-3a extracts, the activities of the latter two were not significantly altered. This rules out, to a great extent, (a) a free inhibitor, (b) an unsatisfied cofactor requirement, and (c) a reaction which competes with the synthesis of US, as causal factors in the inability of pyr-3d to yield aspartic carbamyl transferase activity.
The relationship of the activity, or lack of it, in pyr-3a, 3b, 3d and wild type was the same if untreated extracts of fresh homogenized mycelia were used instead of acetone powder extracts.
Discussion.-The foregoing data clearly indicate that the pyr-3a and pyr-3b mutations are not correlated with significant changes in the enzyme aspartic carbamyl transferase with regard to differences in its activity at different temperatures, pH's, or substrate concentrations. The enzyme activity of pyr-3d extracts, on the other hand, has been found to be less than one per cent that of similar extracts of wild type mycelia. The enzymatic difference between the pyr-3 mutants corresponds to that observed in studies of their genetics," 2 heterocaryon comple- mentation," 2 and suppressor response.' Four other pyrimidine-requiring strains presumed to represent the pyr-3 locus, 49001, 63902, 68902, and 47102, have also been found to lack aspartic carbamyl transferase activity. (Mutant 49001 has been tested and found to resemble pyr-3d in its lack of response to the suppressor.') It may be concluded that the lack of aspartic carbamyl transferase activity in these strains and in pyr-3d is directly related to the pyrimidine requirement of the mutants themselves. In light of the findings reported here, it is improbable that the series of pyr-3 mutations directly affects only one enzyme. What has been designated as the "pyr-3" locus, a genetic complex covering less than (0.05) map units, is undoubtedly concerned with more than a single function.
These data further show that the inability of pyr-3d to grow on medium supplemented with US does not reflect the site of the metabolic block in this mutant. '7 There is, therefore, no reason to think that a similar lack of response to US by pyr-3a and 3b is significant either. This suggestion, together with the preliminary enzymatic data orn pyr-3 mutants referred to above, allow the assumption that pyr-3a and Ab are blocked before the synthesis of US.
The nature of the biochemical lesion in pyr-3a and 3b, however, has not yet been elucidated. In a series of experiments, Mitchell and Mitchell'8 made observations of the nutritional requirements of strains carrying any one of several arginine mutations and pyr-3a or s. Their data imply that there is a significant connection between the metabolic block in pyr-3a and the synthesis of arginine, and that the synthesis of arginine and pyrimidines is to some extent competitive. Such a competition may operate in the utilization of carbamyl phosphate or aspartic acid, both of which are normally required in pyrimidine and arginine synthesis. A Summary.-Several pyrimidine-requiring mutants of Neurospora crassa, presumed to represent a single locus (pyr-3), have been studied in regard to the activity of aspartic carbamyl transferase of mycelia. It has been found that pyr-3d and certain other mutants yield no activity, while pyr-3a and Ab appear to contain an enzyme indistinguishable from that demonstrated in the wild type. The results suggest that the pyr-3 "locus" is concerned with more than a single function.
The author wishes to thank Dr. H. K. Mitchell and Mary B. Mitchell for information and critical discussion during the course of this work. Since the formation of many degradative enzymes is induced by adding to the culture medium the corresponding substrate, it has often been suggested that the "constitutive" nature of biosynthetic enzymes depends on the endogenous formation of their substrates. It would appear possible to test this hypothesis by using a genetic block to prevent this endogenous formation. However, previous attempts to study the problem in this way1' 2 have led to inconclusive results, since growth on the substrate was compared with growth on the end product of the biosynthetic sequence, and this end product has since been found to repress the formation of the enzyme. Furthermore, the added substrate was also serving as a source of the repressor. An additional possible complication of such experiments is formation of the substrate from the added end product, in those cases where the reactions between the two compounds are reversible.
In undertaking a reinvestigation of this problem with ornithine transcarbamylase of Escherichia coli, an enzyme of arginine biosynthesis which catalyzes the conversion of ornithine to citrulline, we have controlled these interfering factors by two devices: the use of a chemostat and the use of double mutants blocked both before and after the reaction under study. The chemostat made it possible to reduce repression by supplying mutants with the required arginine at low, controlled concentrations.3 In the double mutants (Fig. 1) , the earlier block glutamate 1, o _0ornithine--ocitrulline-, 1arginine
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Step 3 prevents endogenous formation of the substrate (ornithine), while the later block prevents both formation of the end product of the seqence from added substrate and formation of the substrate from added end product. In E. coli there appears to be no additional pathway to ornithine. 4 The study has been extended to include not only arginine-repressible strains but also strains in which arginine does not have this effect.
Bacterial Strains.-In the present experiments the wild type and mutants of different strains of E. coli have been studied: the W strain, in which added arginine
